Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages, according to new calculations released by Cancer Research UK today.
Around 1,100 people in England could miss out on the chance of an early stage bowel cancer diagnosis through screening each year because of NHS staff shortages, according to new calculations released by Cancer Research UK today.
The faecal immunochemical test (FIT) is now an established bowel cancer test. This diagnostic assay identifies the presence of hidden blood in the stool, known as faecal occult blood (FOB), which can be an early sign of colorectal cancer. FIT uses antibodies specific to human haemoglobin so is more accurate and sensitive, provides a quantitative measurement and gives fewer false positive results than other tests.
Read MoreNICE DG56 vs. NICE DG30 March 21, 2024
A New Portal to Ef-FIT-ciency June 16, 2023
Partnership with the NHS Award Winners! December 7, 2021
New Leading Edge Just Launched๐
Articles include:
- Next Level CALEXยฎ Workflow Revolution
- Serum Calprotectin Analysis: ELISA vs. Turbidimetric Assays
- NICE DG56 vs. NICE DG30: Updates to FIT Guidance
Read now: https://files.alphalabs.co.uk/e-mags/Leading_Edge_2024-Issue-1/ #ClinicalDiagnostics #HealthcareInnovation
๐๐ฅ๐๐๐ฌ๐ ๐ซ๐๐ฆ๐๐ฆ๐๐๐ซ ๐ญ๐จ ๐๐๐๐๐ ๐๐ง๐ ๐๐๐๐ ๐ฒ๐จ๐ฎ๐ซ ๐ค๐ข๐ญ ๐๐๐๐จ๐ซ๐ ๐ฉ๐ฎ๐ญ๐ญ๐ข๐ง๐ ๐ข๐ญ ๐ข๐ง ๐ญ๐ก๐ ๐๐ง๐ฏ๐๐ฅ๐จ๐ฉ๐ ๐๐ง๐ ๐ฉ๐จ๐ฌ๐ญ๐ข๐ง๐ ๐ข๐ญ ๐๐๐๐ค ๐ญ๐จ ๐ฎ๐ฌ Lots of kits received without labels and we cannot test them ๐ข#labelyourkit #BowelScreening